Recombinant Zika virus (strain Zika SPH2015) E / Envelope protein (Domain III, His Tag) Antigens The Zika virus (strain Zika SPH2015) E / Envelope (domain III) (ALU33341.1) (Val593-Lys699) was expressed with a polyhistidine tag at the C-terminus. The recombinant Zika virus (strain Zika SPH2015) E / Envelope (domain III) consists of 118a.a and predicts a molecular weight of 13 kDa.
$ $99 In stock
Formulation: The recombinant Zika virus (strain Zika SPH2015) E / Envelope (domain III) consists of 118a.a and predicts a molecular weight of 13 kDa.
Source: Yeast
Usage: Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use.

Recombinant Zika virus (strain Zika SPH2015) E / Envelope protein (Domain III, His Tag)

The product is for non-human research only. Not for therapeutic or veterinary use.

Catalog No: bt-224188

Molecular Weight: The recombinant Zika virus (strain Zika SPH2015) E / Envelope (domain III) consists of 118a.a and predicts a molecular weight of 13 kDa.

Formulation: Recombinant Zika virus (strain Zika SPH2015) E / Envelope Protein was lyophilized from sterile PBS, pH 7.4.1.

Source: Yeast

Product Name Recombinant Zika virus (strain Zika SPH2015) E / Envelope protein (Domain III, His Tag)
Molecular Weight The recombinant Zika virus (strain Zika SPH2015) E / Envelope (domain III) consists of 118a.a and predicts a molecular weight of 13 kDa.
AA Sequence Val593-Lys699
Bioactivity Please contact us for detailed information
Formulation Recombinant Zika virus (strain Zika SPH2015) E / Envelope Protein was lyophilized from sterile PBS, pH 7.4.1.
Description The Zika virus (strain Zika SPH2015) E / Envelope (domain III) (ALU33341.1) (Val593-Lys699) was expressed with a polyhistidine tag at the C-terminus.
Product Background Envelope of Zika virus is resposible for receptor binding and membrane. Analysis of the envelope protein of Zika, from Brazilian Zika SPH215 (KU321639), indicates predicted B and T cell epitopes in peptides that are consistent to those reported for dengue, YFYF and Japanese encephalitis.The envelope Domain II B cell epitope, to which much dengue non-neutralizing cross reaction is attributed, is also conserved also in Zika virus, consistent with prior field observations of cross reactivity with dengue and YF. Domain III of the Zika envelope protein, likely the main specific neutralizing domain, is distinct from recent Brazilian dengue isolates and a recent Peruvian YF isolate (GQ379163), 76% of possible major histocompatibility complex class (MHC) I and MHC II binding peptides and potential B cell linear epitopes are unique to Zika virus.
Product Type Antigen
Purity Greater than 95% as determined by SDS-PAGE.
Source Yeast
Storage Store recombinant protein under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Terminal Val 593
Usage Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use.
Last Modified Mar 08 2019